In patients with diabetic macular edema, small gauge pars plana vitrectomy should be considered as a first-line treatment, ...

DURAVYU has established safety and efficacy data from both Phase 1 and 2 trials in wet AMD and DME that demonstrate stability in vision and anatomical control with a single dose of DURAVYU. No ...

RA tirzepatide for type 2 diabetes mellitus (T2DM) therapy has lower odds of instigating retinal complications.

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

Researchers developed and validated a machine-learning model to differentiate uveitic and diabetic macular edema using ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

New post-hoc analysis of OCT scans on GCIPL and analysis of responders with improvement of 15 or 30-letter on low-contrast visual acuity (LCVA) from the Phase 2 ACUITY trial with Privosegtor, to be ...

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association ...

Damon Wayans raises awareness about diabetic macular edema, a hidden diabetes risk that can cause vision loss, and urges people to get regular eye exams Damon Wayans is raising awareness of diabetic ...

Comedy icon Damon Wayans was diagnosed with Type 2 diabetes in 2008. Now, he is teaming up with Genentech and diaTribe as he serves as the spokesperson for "All Eyes on DME," a campaign designed to ...